１　発病のとき

A A 1944 19 60 A 1 A 20 40 2 A 4 A A 23 6 A A 13 10 100 2 2 360 A 19 2 5 A A A A A TS TS A A A 194823 6 A A 23 A 361 A 3 2 4 2 16 9 A 7 18 A A 16 4 16 3 362 A A 6 A 6 4 A A 363 A 1 A A 1 A A 364 A 1 A

2

2

2

0

5 A 1944 19 60 1944 19 2 5 A A A 4 B 1945 20 59 B 3 B B 24 C 1943 18 60 C 8 D 1949 24 55 D 3 E 1932 7 71 E 11 8 E E 5 C C 8 C 2 C 4 D 2 E A B 341 A C A A C E E E B 342 B B C C 5 D 3 D 41 11 343 C C C A

c o n t e n t s 3 1 4 2 6 3 8 4 10 5 HIV12 6 14 16 HIV18?20 22 LGBT HIV???? 6 4 LGBT L G B T 4 LGBT 2 3

HIV HIV 201631 164-0003 1-57-241 FAX: 03-6279-3094E-mail: info@purple-hands.net NPO c o n t e n t s 3 1 4 2 6 3 8 4 10 5 HIV12 6 14 16 HIV18?20 22 LGBT HIV???? 6 4 LGBT L G B T 4 LGBT 2 3 4 5 20156 201511

,,

教室案内.pptx

株主通信：第16期 中間報告書

9 1 20,000 15,000 10,000 5,000 2007/4 2008/4 2009/4 2010/4 2011/4 2012/4 2013/4 01 02 2 3 03 04 4 05 06 5 133,362 206,945 344,360 363,936 67,583 128,114 819 18,583 412,477 846,445 164,935 422,265 1,433,645

P15 P211 1 P1 P4 P2 P3 P4 P17

P15 P211 1 P1 P4 P2 P3 P4 P17 P3 P4 P7 P8 P9 2 1 Q A P17 P17 1 2 3 4 3 5 6 7 8 2 P17 Q A P17 4 1 2 3 4 2 P17 P4 P12 P17 P4 5 5 6 7 8 2 P4 P4 6 1 2 3 4 3 P17 P10 P17 7 5 6 7 8 4 0120-096-991 P17 8 1 2 3

untitled

untitled

...1...3 -... 3 -... 3...5 -... 5 -... 5 -... 6 -... 7 -... 7 -... 7 -... 10 -... 17 -... 17 -... 18 -... 20 -... 21 1 TEL 2 3 4 ) ) 5 6 7 8 9 10 11 () (4) () (4) () () 730-0042730-8586 730-0042 730-0042730-8586

フィナレビ106号.indb

2009 3 30 2009 4 14 CDC 2009 4 25 WHO 2009 4 26 2009 4 28 2009 4 28 2009 4 30 2009 5 1 2009 5 8 6 2009 5 9 2009 5 23 2009 6 3 2009 6 9 2500 2009 6 12 WHO 6 2009 6 28 2009 8 9 1 1 2009 8 15 2009 8 19 2010

シェアリングレター 第３０号

～～濱田のジイサンとの出会い～～

.\1-.\4_0204

MultiWriter 5650C 活用マニュアル

1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 11 1 2 3 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 1 2 3 a b c 30 31 32 C *1 *2 *2 33 2 2 2 2 2 2 2 2 2 34 *1 *2 ± *1 C C 35 36 37 38 39 40 OK 1 2 3 4

pera1会社概要n

1% 51% 4% 13% 31% 152 50 47 36 32 21 20 20 16 14 7 3 1

1% 13 13 19 20 1% 80 9% 70 41% 60 34% 30 3% 40 5% 50 6% 51% 2% 47% 3% 1% 14% 10% 23% 49% 1% 51% 4% 13% 31% 152 50 47 36 32 21 20 20 16 14 7 3 1 102 228 OK 228 46 42 17 10 8 6 5 1 14% 25% 1% 3% 7% 27% 23%

エンジョイ北スポーツ

2772083130 83 1 2 3 4 5 6 7 8 2 2 2 3 3 4 4 6 7 8 1211 53 /15,171 /509 /670 /13,992 2 83130 http://www.kita-city-taikyo.or.jp 83130 http://www.kita-city-taikyo.or.jp 3 68 35 45 4 83130 http://www.kita-city-taikyo.or.jp

TimeServer_outer.ai

untitled

世田谷区新型インフルエンザ対策行動計画

7

h1_h4.eps

A P18 P11 P P1 P4 P17 P3 P4 1

A P18 P11 P P1 P4 P17 P3 P4 1 P3 P4 P7 P8 P9 1 Q A 1 3 4 P17 P17 3 6 7 8 P17 P13 Q A P17 4 1 3 4 P17 P14 P4 P13 P17 P4 6 7 8 P4 P4 6 1 3 4 3 P17 P17 7 6 7 8 4 010-096-991 P17 8 1 3 4 P17 P17 Q A 9 6 7

1 2 3 1 34060120 1,00040 2,000 1 5 10 50 2014B 305,000140 285 5 6 9 1,838 50 922 78 5025 50 10 1 2

0120-563-506 / 9001800 9001700 123113 0120-860-777 163-8626 6-13-1 Tel.03-6742-3111 http://www.himawari-life.co.jp 1 2 3 1 34060120 1,00040 2,000 1 5 10 50 2014B 305,000140 285 5 6 9 1,838 50 922 78 5025

調査員マニュアル

Interviewer Manual 1998 1 26 - 1 - - 2 - Japan Marketing Research Association - 3 - - 4 - - 5 - JMRA Marketing Research Quality Standard - 6 - - 7 - - 9 - - 10 - - 11 - Don t Know No Answer - 12 - - 13

(2-3)CyberSpace

28 3 21 7 10 22 2 2

28 10 2 () 1 28 3 21 7 10 22 2 2 28 1. 2. () 28 6 29 11 3. 4. 5. ) 6. 7. 3 28 5 IC 28 5 28 6 1.5 2 28 7 1 28 9 28 9. OK 7 28 14 28 15 28 22 22 7 10 200 2 22 10 9 100 23 2 12 100 FAX 1 2 TEL FAX 16 28 20

105-117.PDF

47 2013. 1 6 1 1 2 1 1 2 19832002 2008 4 3 1 1 2008 1 3 6 1 1 22 3 A 24 3 3 2 22 910 3 6090 IC 4 5 A 3 143 133 99 27 27 A 6 1 3 6 1 1 C A C A 6 1 2 C B A B C 3 C 2 3 2 2 1 A OK B 2 C 3 3 3 3 1 B A 2 C

Audiology Japan 45, 2002

Audiology Japan 45, 2002 Audiology Japan 45, 2002 Audiology Japan 45, 2002 Audiology Japan 45, 2002 Audiology Japan 45, 2002 12 Audiology Japan 45, 2002 14 Audiology Japan 45, 2002 16 Audiology

FMV-TEOシリーズ（2008年6月版）製品カタログ

1

1 2 INDEX 3 4 5 6 7 8 60100150200 2 300 60 16 113 134 155 123 100 28 174 215 600 183 150 214 40 200 183 183 60 100 40 150 3 4 5 60 100 150 200 25 1150120 1150120 1150120 2640 1250120 1250120 1250120 200

untitled

CHO015-016_CS3.indd

大学等学校法人の人事制度改定ーActibookPDF.indd

Microsoft Word - レインボープライド2017来場者アンケート報告書.docx

2018 2 2017 4-10 Q1 2017 10 Q2 10,11 Q3 11 Q4 11-13 Q4SQ1 14-16 Q5 16-17 Q6 17 Q7 LGBT 17-18 Q7SQ1 LGBT 18 Q8 LGBT 18-19 Q8SQ1 LGBT 19 Q8SQ2 LGBT 20 Q9 LGBT 20 Q9SQ1 LGBT 21 Q9SQ2 LGBT 21-22 Q10 LGBT 22

untitled

untitled

1 JAPAN TESTING ASSOCIATION 2 3 JAPAN TESTING ASSOCIATION 4 5 JAPAN TESTING ASSOCIATION 6 7 JAPAN TESTING ASSOCIATION 8 9 JAPAN TESTING ASSOCIATION 10 11 JAPAN TESTING ASSOCIATION 12 13 JAPAN TESTING ASSOCIATION

p 6 7 8 9 10 u u Medical Excellence JAPAN C C 19 35.00% 34.00% 33.00% 32.00% 31.00% 30.00% 29.00% 28.00% 27.00% 34.62% 32.11% 29.97% 29.74% 2014 201520162018 ,, H26.6.23, 9.24/ H27.3.11,

00_cover1_2.pm6

アプリケーションソフトウェアガイド PM2200C用

4013356-01 C01 1 2 3 4 5 6 7 8 9 10 11 12 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Printed

1 2 1, 2 F64 Gender identity disorder GID 1 2 3 1 2 1 2 3 M F 4 B 1 W 2 3 4 2007 10 22 (1) 2007 11 19 2007 12 17 2007 11 19 2007 12 17 2007 11 19 2007 12 17 (2) 2007 11 19 2007 12 17 2007 11 19

改善活動が加速する 社内ネットワーク ～SPI車座集会と社内SNS ～

Japan Arts Fund No.20

PowerPoint プレゼンテーション

1 2 20083 3 4 5 6 7 8 2008 10-12 2008 10-12 2007 10-12 669 749 700 7.0 % 70 116 99 16.5 % 599 633 600 5.4 % 331 331 312 6.0 % 328 328 308 6.5 % 191 191 171 11.4 % EPS 322 322 283 13.6 % 5,928 5,928 6,048-2.0

筆王 for NEC

2 d 3 4 5 q w e r w e r q 6 q w q e 7 8 9 q q w w q w q w 10 11 12 q w 13 e q w e 14 q w q w e 15 r e 16 17 18 q w e 20 r q w t y q w e 21 u v v i o 22 !0!1!2 23 q w e 24 q w q w e e r y 25 q q w w q

2000 500 30 4000 60 2000 30 2000 15 500 50 4000 70 80 2000

2

1 2 3 4 5 6 7 8 9 10 11 12 ( ) RAND [OK] 0 1 13 14 15 16 17 18 19 20 21 1 22 23 24 25 26 27 28 ( ) DDE ( ) ( ) ( ) ( ): ( ): ( ): 29 30 1 1 1 1 31 32 33 34 35 36 37 38 39 40 41 : : : : : ( ) : : 1 42 43

Word 2000 Standard

.1.1 [ ]-[ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [OK] [ ] 1 .1.2 [ ]-[ ] [ ] [ ] [ [ ] [ ][ ] [ ] [ ] [ / ] [OK] [ ] [ ] [ ] [ ] 2 [OK] [ ] [ ] .2.1 [ ]-[ ] [F5] [ ] [ ] [] [ ] [ ] [ ] [ ] 4 ..1 [ ]-[ ] 5 ..2

Microsoft Word - ????0803.docx

untitled

20 20 6 30 18 30 20 30 1 1 1 2 3 10 2 2 2 22 6 29 2 7 1 2 11 3 21 2 4 6 3 5 9 6 22 2 2 6 7 2 1 16 10 1 16 10 10 2 4 3 3 A4 3 1 2 3 1 55 8 4 63 11 4 8 8 4 8 12 2 17 11 4 4 4 8 12 3 5 4 8 4 12 5 5 6 19 2

表紙

Microsoft PowerPoint - gid2004_v4.ppt

: MRI 24. 3. 2-21 6 GID GID GID GID (Gender Identity Disorder GID) (Transsexualism TS) (SRS) MTF (Male to Female TS) FTM (Female to Male TS) Gender dysphoria syndrome ( ) Gender identity disorder (GID)

<96A297888AD933352E706466>

2003 10 2003.10.21 70.400 YES NO NO YES YES NO YES NO YES NO YES NO NO 20 20 50m 12m 12m 0.1 ha 4.0m 6.0m 0.3 ha 4.0m 6.0m 6.0m 0.3 0.6ha 4.5m 6.0m 6.0m 0.6 1.0ha 5.5m 6.5m 6.0m 50m 18 OK a a a a b a

untitled

Molecular Devices Japan KK / Imaging Team (1/11) Molecular Devices Japan KK / Imaging Team (2/11) Language for non-unicode programs English (United States) Japanese OK Molecular Devices Japan KK / Imaging

B B () 67

() 66 B B () 67 ) 68 () ) 69 70 21 12 25 NPO 73 (NPO ) 71 72 73 74 75 22 3 18 M 23 ( ) 76 150 21 10 24 26 77 78 79 3 ) 80 81 82 83 OK OK 84 21 10 28 12 () () 85 86 87 TEL 078-362-3169 E-maildanjokatei@pref.hyogo.lg.jp

(1) %

1 (2008.9.20) 3 (1) 2006 92% 200 200 5 6 2006 2006 2 30 5 2006 1 4 5 3 (3 ) 6000 7000 6000 7000 30 NHK 12.5% 24.1% 4 1 10 4 2006 1 3 2006 2006 (2) (a)90 2006 2006 12 3 90 (1) 3 40 50 30 40 40 50 4 5 30

Vol103.indd

3 4 6 7 4 12 1 10 10 70 1 1 525 4 1 3 1 170 30 3 JR 40 1 4 3 9 4 4 4 7 1 3 3 3 1 2

1 18 2 500 125 500 10 3 500 2 40 2 1 7... 40 23 5 18 1 3 4 6 7 4 12 1 10 10 70 1 1 525 4 1 3 1 170 30 3 JR 40 1 4 3 9 4 4 4 7 1 3 3 3 1 2 3 2 2 7 30 1 8 2 15 1 1 15 15 1 2 10.6km 30 8 30 9 10 3 9 50 30

JAPAN MARKETING JOURNAL 113 Vol.29 No.12009

JAPAN MARKETING JOURNAL 113 Vol.29 No.12009 JAPAN MARKETING JOURNAL 113 Vol.29 No.12009 JAPAN MARKETING JOURNAL 113 Vol.29 No.12009 JAPAN MARKETING JOURNAL 113 Vol.29 No.12009 Vol.29 No.12009 JAPAN MARKETING

JAPAN MARKETING JOURNAL 111 Vol.28 No.32008

Vol.28 No.32008 JAPAN MARKETING JOURNAL 111 Vol.28 No.32008 JAPAN MARKETING JOURNAL 111 Vol.28 No.32008 JAPAN MARKETING JOURNAL 111 Vol.28 No.32008 JAPAN MARKETING JOURNAL 111 Vol.28 No.32008 JAPAN MARKETING

JAPAN MARKETING JOURNAL 110 Vol.28 No.22008

Vol.28 No.22008 JAPAN MARKETING JOURNAL 110 Vol.28 No.22008 JAPAN MARKETING JOURNAL 110 Vol.28 No.22008 JAPAN MARKETING JOURNAL 110 Vol.28 No.22008 JAPAN MARKETING JOURNAL 110 Vol.28 No.22008 JAPAN MARKETING

１　発病のとき

1 3 2002 11 26 27 5 2003 1 15 16 9 2003 4 16 17 10 2003 6 25 26 12 2003 9 17 13 2003 11 12 13 16 2004 4 21 22 17 2004 5 19 20 18 2004 6 15 17 2004 6 17 20 2004 7 14 15 21 2004 8 18 19 2004 8 19 22 2004

267.indd

untitled

28 20 1 31 4 2 25 1 IgG IgA IgM IgE IgM 2 60 80 70 60 60 40 20 80 35 45 kg 150cc 100 120cc 100cc 30 40cc 7,000g 500cc 120cc 120 5=600cc 600g 30 2,100cc 1,000cc 3 4 14 5 6 7 8 9 10 11 12 SIDS SIDS SIDS

佛大_総合案内A4.indd

1 KYOTO JAPAN 2 BUKKYO 3 KYOTO JAPAN 4 BUKKYO 5 KYOTO JAPAN 6 BUKKYO 7 KYOTO JAPAN 8 BUKKYO 9 KYOTO JAPAN 10 BUKKYO 11 KYOTO JAPAN 12 BUKKYO 13 KYOTO JAPAN 14 BUKKYO KYOTO JAPAN 15 16 BUKKYO 17 KYOTO JAPAN

2 1

untitled

untitled

untitled

untitled

78p1RGB.pdf

2001 11 14 19971219947 2 13 4 1 1 1 1 200 1000 1 1 00 2 3 30 100 3 5000 5 1 100 1 100 4 5 6 1 26,234 12,084 9,142 26,916 7 , 1 1 4 8 3 9 100 1895 3516870 100 10 11 W 14 15 New 16 W 11 14 21 1 W 63

EPSON PX-G920 基本操作ガイド

2

- 2 Copyright (C) 2006. All Rights Reserved.

- 2 Copyright (C) 2006. All Rights Reserved. 2-3 Copyright (C) 2006. All Rights Reserved. 70-4 Copyright (C) 2006. All Rights Reserved. ...1...3...7...8 1...9...14...16 2...18...20...21 3...22...23...23...24

, TV,

Booklet_038_Monsanto

2013 Democracy Now! Japan 2 http://democracynow.jp/ 1 2013 Democracy Now! Japan 3 http://democracynow.jp/ 2013 Democracy Now! Japan 4 http://democracynow.jp/ 10 2013 Democracy Now! Japan 5 http://democracynow.jp/

EPSON PX-A720 操作ガイド

o n h l m l m l m l m m o h n h h h h h h h h h h h h h h h n h h h h o h o o o h o o h h h h n h n D A h B C n E F h G n h h h h o n o h h h n h h A h h B h C n D A h B h C E h E F D n A B A h C D

e-tax e-tax e-tax e-tax OK 2e-Tax

e-tax e-tax 3-1 e-tax...31 3-2...34...34...35 3-3...36...36...39...40...41...42...44 3-4 e-tax...45 3-5...46...46 2...48 e-tax e-tax e-tax e-tax OK 2e-Tax e-tax e-tax 4-1 16 4 30 e-tax 2 4-2 e-tax e-tax

152 NPO,,

151 NPO NPO NPO FM NPO NPO 152 NPO,, NPO 153 154 NPO NPO 155 156 NPO FAX , NPO 157 158 NPO NPO OB NPO NPO NPO NPO, NPO 159,.,,,,, 160 NPO, NPO NPO NPO NPO PR NPO 161 162 NPO NPO NPO NPO NPO NPO NPO NPO

Core Ethics Vol. Sex Reassignment Surgery SRS SRS GID GID SRS GID GID GID GID GID QOL QOL QOL -- QOL

Core Ethics Vol. MTF Gender Identity Disorder GID GID GID GID QOL GID QOL QOL GID QOL GID QOL QOL QOL GID QOL Gender Identity Disorder QOL GID Core Ethics Vol. Sex Reassignment Surgery SRS SRS GID GID